Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Mitchell Cole
It Ends: The Horror of Nothing Happening
Synopsis: Four recent graduates take a late-night drive for food, make one wrong turn, and find themselves on a two-lane road that refuses to end. Stars: Phinehas Yoon, Akira Jackson, Noah Toth, Mitchell Cole Director: Alexander Ullom Rated: R (pervasive language) Running Length: 89 minutes Movie Review in Brief: A micro-budget debut that turns an endless highway into a study of how long people will keep driving toward nothing.
It Ends Reviews - Metacritic
Available after 4 critic reviews User reviews are not available yet Available after 4 critic reviews 100% Positive 2 Reviews 0% Mixed 0 Reviews 0% Negative 0 Reviews Mar 14, 2025 The Playlist It’s a simple yet effectively haunting work that’s well-shot, written, and acted across the board, especially for a first feature that takes on as much as this does. Mar 26, 2025 Collider It Ends takes viewers for a terrifying ride in unexpected ways.
where to watch movie online?
We try to add new providers constantly but we couldn't find an offer for "It Ends" online. Please come back again soon to check if there's something new.
Repeal of ACA’s Pre-Existing Condition Protections Could Affect Health Security of Over 100 Million People
Summary New analysis from Avalere finds that 102 million individuals, not enrolled in major public programs like Medicaid or Medicare, have a pre-existing medical condition and could therefore face higher premiums or significant out-of-pocket costs if the ACA’s pre-existing condition protections were repealed.
Majority of API in US-Consumed Medicines is Produced in the US
The US healthcare system relies on the domestic production of active pharmaceutical ingredients (API) supplemented by imports. Avalere’s analysis finds that in 2019, the dollar value of API made in the US accounted for a majority (54%) of the $86.5 billion of API used in medicines consumed in the US. Total dollar value of API made in European Union member states accounted for 26%.
Nektar Therapeutics (NKTR) is trading with P/E ratio of 8.15
Nektar Therapeutics (NKTR) broke hearts of Investors, when its current damaging image was observed. The stock price is indicating discouraging picture with current steep move of -17.22% at exchanging price of $39.89. Currently Analysts have a mean recommendation of 1.80 on the shares. This is based on a 1-5 numeric scale where Rating Scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell, 5.0 Strong Sell. The total dollar value of all 177.37 million outstanding shares is 7.08 billion.
Editas Medicine, Inc. (EDIT) moved -10.59% - Monthly Down Overview
Editas Medicine, Inc. (EDIT) recently closed with fall of EDIT stock price moved downswing along with the volume 0.8 million shares in Thursday session. Shares are closed price at $28.61 with change of -5.30%. The total dollar value of all 51.59 million outstanding shares is 1.48 billion. The company’s 3-months average volume stands at 0.75 million. When we divide the last trade volume by the 3-month average volume, we found out a relative volume of 1.06.
Novavax, Inc. (NVAX) returned 19.23% high - Monthly Gainer
Novavax, Inc. (NVAX) recently closed with rise of NVAX stock price moved Upswing along with the volume 6.45 million shares in Yesterday session. Shares are closed price at $1.86 with change of 0.00%. The total dollar value of all 351.50 million outstanding shares is 0.65 billion. The company’s 3-months average volume stands at 4.86 million. When we divide the last trade volume by the 3-month average volume, we found out a relative volume of 1.34.
CRISPR Therapeutics AG (CRSP) returned -9.00% low in last month
CRISPR Therapeutics AG (CRSP) recently closed with fall of CRSP stock price moved downswing along with the volume 5.86 million shares in Friday session. Shares are closed price at $44.49 with change of -9.19%. The total dollar value of all 46.55 million outstanding shares is 2.07 billion. The company’s 3-months average volume stands at 0.87 million. When we divide the last trade volume by the 3-month average volume, we found out a relative volume of 6.70.
Hold Recommendation? CRISPR Therapeutics AG (CRSP)
A glance over shares of CRISPR Therapeutics AG (CRSP) price that shifted -0.29% away from 20-Days Simple Moving Average, -7.60% from 50-Days Simple Moving Average and separated 8.61% from 200 Days Simple Moving Average. CRISPR Therapeutics AG (CRSP) declared loss -6.68% in latest trading session with settlement price of $ 49.88. The stock’s changed hands 0.66 million shares in session while it possesses an average volume of 1.11 million shares.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mitchell
Contact Mitchell, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack